NEUTRINZA

Marca svizra · 636394 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
636394
Numer da la dumonda
54323/2012
Status
Stizzada
Tip
Marca da pled
Deponida
12-04-2012
Registrada
14-11-2012
Publitgada
14-11-2012
Stizzada
04-11-2022
Motiv
Betg prolungada
Prioritad
17.11.2011 US
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von neurologischen Störungen.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-11-2022

    Stritgà, betg prolungà

    Published in Swissreg on 04.11.2022

  2. 19-10-2022

    Adressa dal possessur midada

    Owner
    Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA → Biogen MA Inc., 225 Binney Street, Cambridge, MA 02142, USA

    Published in Swissreg on 19.10.2022

  3. 24-05-2016

    Adressa dal possessur midada

    Owner
    Biogen Idec MA Inc., 14 Cambridge Center, Cambridge, MA 02142, USA → Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA

    Published in Swissreg on 24.05.2016

  4. 14-11-2012

    Registrà

    Published in Swissreg on 14.11.2012

Partidas

Possessura

Biogen MA Inc.

225 Binney Street, Cambridge, MA 02142, US

Represententa

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.